A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents
Andrea Picchianti Diamanti(Sapienza University of Rome), Bruno Laganà, Roberta Rosa(University of Naples Federico II), Concetta Panebianco(Casa Sollievo della Sofferenza), Valeria Di Gioia(Sapienza University of Rome), Gerardo Salerno(Sapienza University of Rome), Giorgio Sesti(Sapienza University of Rome), Gabriele Nalli, Simonetta Salemi(Sapienza University of Rome), Ilaria Anna Bellofatto(University of Genoa), Concetta Finocchiaro(University of Catania)
Cited by 6
Related Papers
Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): <scp>D</scp> ata from randomized controlled trials
|Diabetes Obesity and Metabolism|2017|226
The nutritional risk in oncology: a study of 1,453 cancer outpatients
|Supportive Care in Cancer|2012|210
Review of methods for detecting glycemic disorders
|Diabetes Research and Clinical Practice|2020|193
Diet-Gut Microbiota Interactions and Gestational Diabetes Mellitus (GDM)
|Nutrients|2019|167
Mechanisms of lapatinib resistance in HER2-driven breast cancer
|Cancer Treatment Reviews|2015|162